Department of Radiology, Mayo Clinic, Rochester, MN, USA.
Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Abdom Radiol (NY). 2016 Oct;41(10):2061-77. doi: 10.1007/s00261-016-0768-x.
Stereotactic body radiation therapy (SBRT) is a noninvasive treatment technique for selected patients with primary liver tumors and liver-confined oligometastatic disease. Recently, SBRT has emerged as an alternative treatment option in non-surgical candidates and in whom percutaneous treatment methods are not possible or contraindicated. The experience with SBRT continues to grow. There are currently no imaging guidelines for assessment of tumor response and follow-up schedule following SBRT. SBRT produces characteristic radiation-induced changes in the treated tumor and surrounding liver parenchyma. Knowledge of these changes is essential in the interpretation of follow-up imaging and assessment of treatment response. In this review, we will describe the CT, MRI, and PET imaging findings following SBRT of both the targeted liver tumor and surrounding hepatic parenchyma.
立体定向体部放射治疗(SBRT)是一种针对原发性肝肿瘤和肝寡转移病灶的非侵入性治疗技术。最近,SBRT 已成为非手术患者和经皮治疗方法不可行或禁忌的患者的替代治疗选择。SBRT 的经验不断增加。目前尚无评估肿瘤反应和 SBRT 后随访计划的影像学指南。SBRT 会在治疗后的肿瘤和周围肝实质中产生特征性的辐射诱导变化。了解这些变化对于解读随访影像学和评估治疗反应至关重要。在这篇综述中,我们将描述 SBRT 后靶向肝肿瘤和周围肝实质的 CT、MRI 和 PET 成像表现。